KanonCure

Vision

  Under the world's most advanced research and development environment in the regenerative medicine area in Japan, we are aiming to achieve a medical innovation through our unique and cutting-edge cell therapy technology in the liver disease field, where all the patients in the world may be able to undergo ultimate and safer treatment to realize a healty longevity society.
Product
Regenerative Medicine Liver disease treatment with liver cell sheets
  We are developing the new regenerative medicine for liver disease, using liver cell sheets which are differentiated with a low molecular weight compounds from mesenchymal stem cells (MSCs).
事業概要
Drug Discovery Liver disease treatment with low-molecular-weight compounds
  In the middle term, we are also developing a new liver desease treatment with novel low-molecular-weight compounds for liver regeneration.

Reference

1. Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells. Regenerative Therapy 2015, 2:32-41.
 PDF(2.8MB)

2. Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice. Sci Rep. 2015, 5: 16169.
 PDF(2.7MB)


<< Back